DNAPartnership•businesswire•
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
Sentiment:Positive (70)
Summary
(NYSE:DNA) BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks announced a series of new initiatives to accelerate the application of artificial intelligence in biologics drug discovery.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 4, 2025 by businesswire